Unibest

Pharmaceutical intermediates

Entrectinib Intermediates

6 pharmaceutical intermediates for Entrectinib. Indication: Solid tumours; Carcinoma, Non-Small-Cell Lung.

提交项目All intermediates

About Entrectinib

Originator
Nerviano Medical Sciences Srl
Indication
Solid tumours; Carcinoma, Non-Small-Cell Lung
Approved Date
08/15/2019
DS/DP
07/08/2028

Available intermediates

6 intermediates currently listed for Entrectinib. Request specifications, documentation or a quotation for any item below.

Entrectinib intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
5-(3,5-difluorobenzyl)-1H-indazol-3-amine1108745-30-7//
tert-butyl 4-(4-methylpiperazin-1-yl)-2-nitrobenzoate942271-61-6//
5-(3,5-difluorobenzyl)-2-fluorobenzonitrile1108745-25-0//
tert-butyl 2-amino-4-(4-methylpiperazin-1-yl)benzoate1034975-35-3//
4-(4-methylpiperazin-1-yl)-2-[(tetrahydropyran-4-yl)(2,2,2-trifluoroacetyl)amino]benzoic acid trifluoroacetate1034975-62-6//
4-(4-methylpiperazin-1-yl)-2-(2,2,2-trifluoro-N-(tetrahydro-2H-pyran-4-yl)acetamido)benzoicacid1034975-61-5//

Other programs under E

Edoxaban tosylate monohydrateElacestrantElagolix SodiumEldecalcitolElinzanetantElobixibatEltrombopagEltrombopag Olamine

Building toward Entrectinib?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →